THOUSANDS of CBD businesses are expecting to have their products validated over the coming weeks with two of the main
TENACIOUS Labs, which launched into the cannabis market last year with a flurry of acquisitions across the US and UK,
AS Brains Bioceutical becomes the latest company to make it on to the Public List of Validated Novel Food CBD
THE UK Food Standards Agency has set a new deadline of the end of February for the submission of data
Sativa Wellness Group is pleased to announce a change of name to Goodbody Health Inc to align the parent company
METRO Bank, one of the few institutions in the UK open to working with cannabis-related companies, is now closing its
CHILL Brands Group saw its stock prices jump as much as 25% after announcing the appointment of Michael Sandore as
In a Q&A with BusinessCann Eoin Keenan, CEO & Co-Founder, Goodrays, says after seven years working in the industry he
MUCH-AWAITED guidance on the permitted levels of THC in UK CBD products has been met with a mixed response and
IT’S still early days but after a faltering start by its North American neighbours US cannabis companies are now taking
British Company, Dragonfly Biosciences UK, the makers of Dragonfly CBD, Europe’s largest and leading, award winning seed to shelf range of CBD oils and
THE head of the Food Standards Agency (FSA) says it is now only a matter of weeks before it publishes
CELLULAR Goods has announced that health and beauty industry veteran Anna Chokina has replaced Alexis Abraham as its new CEO
THE CBD industry is being failed by ‘unnecessary’ ‘unethical’ and ‘unscientific’ directions from the UK regulators, claim the authors of
By Adrian Clarke, Chief Commercial Officer at Tenacious Labs 2021 is proving to be been a momentous one for the
Yooma Wellness Inc. (CSE:YOOM; AQSE:YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and
CHILL Brands Group, a retailer of CBD products in the US, UK and Europe, has seen some £180m wiped off
SUGGESTIONS that CBD is a fad – a boom-to-bust market – with the latter imminent, raised a few eyebrows at
We won’t spam you
